The patent covers long-acting variants of C-Type Natriuretic Peptide (CNP). BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.) The legal action, which would result in a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈